CNR1 and Sepsis: In a lipopolysaccharide (LPS) induced experimental sepsis model, we demonstrated that inhibition of CB1R by its antagonist, AM281, significantly reduced leukocyte activation and improved intestinal microcirculation (Kianian et al., 2014) and iris microcirculation (Kelly et al., 2010; Al-Banna et al., 2013).